Long‐Term Real‐World Survival of Immunotherapy Compared to Chemotherapy for Metastatic Nonsmall Cell Lung Cancer: A Propensity Score‐Matched Analysis

Long‐Term Real‐World Survival of Immunotherapy Compared to Chemotherapy for Metastatic Nonsmall Cell Lung Cancer: A Propensity Score‐Matched Analysis

ABSTRACT Background The long‐term real‐world effect of immunotherapy (IO) is uncertain in metastatic nonsmall cell lung cancer (mNSCLC). This retrospective observational study aimed to describe treatment patterns following the introduction of IO, estimate real‐world treatment effects of IO compared...

Full description

Bibliographic Details
Main Authors: Kun Kim, Michael Sweeting, Linus Jönsson, Nils Wilking
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Thoracic Cancer
Subjects:
cancer immunotherapy
crossover effects
metastatic non‐small cell lung cancer
propensity score matching
real‐world evidence
survival analysis
Online Access:https://doi.org/10.1111/1759-7714.15535

Internet

https://doi.org/10.1111/1759-7714.15535

Similar Items